Clayton PE - Search Results

1

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.

Boguszewski MCS, Boguszewski CL, Chemaitilly W, Cohen LE, Gebauer J, Higham C, Hoffman AR, Polak M, Yuen KCJ, Alos N, Antal Z, Bidlingmaier M, Biller BMK, Brabant G, Choong CSY, Cianfarani S, Clayton PE, Coutant R, Cardoso-Demartini AA, Fernandez A, Grimberg A, Guðmundsson K, Guevara-Aguirre J, Ho KKY, Horikawa R, Isidori AM, Jørgensen JOL, Kamenicky P, Karavitaki N, Kopchick JJ, Lodish M, Luo X, McCormack AI, Meacham L, Melmed S, Mostoufi Moab S, Müller HL, Neggers SJCMM, Aguiar Oliveira MH, Ozono K, Pennisi PA, Popovic V, Radovick S, Savendahl L, Touraine P, van Santen HM, Johannsson G. Boguszewski MCS, et al. Among authors: clayton pe. Eur J Endocrinol. 2022 Apr 21;186(6):P35-P52. doi: 10.1530/EJE-21-1186. Eur J Endocrinol. 2022. PMID: 35319491 Free PMC article. Review.

2

Growth hormone and tumour recurrence.

Ogilvy-Stuart AL, Ryder WD, Gattamaneni HR, Clayton PE, Shalet SM. Ogilvy-Stuart AL, et al. Among authors: clayton pe. BMJ. 1992 Jun 20;304(6842):1601-5. doi: 10.1136/bmj.304.6842.1601. BMJ. 1992. PMID: 1628087 Free PMC article.

3

Growth response to growth hormone therapy following craniospinal irradiation.

Clayton PE, Shalet SM, Price DA. Clayton PE, et al. Eur J Pediatr. 1988 Aug;147(6):597-601. doi: 10.1007/BF00442471. Eur J Pediatr. 1988. PMID: 3181200

4

Growth and growth hormone responses to oxandrolone in boys with constitutional delay of growth and puberty (CDGP).

Clayton PE, Shalet SM, Price DA, Addison GM. Clayton PE, et al. Clin Endocrinol (Oxf). 1988 Aug;29(2):123-30. doi: 10.1111/j.1365-2265.1988.tb00254.x. Clin Endocrinol (Oxf). 1988. PMID: 3248354 Clinical Trial.

5

Urinary growth hormone excretion in the assessment of children with disorders of growth.

Skinner AM, Clayton PE, Price DA, Addison GM, Soo A. Skinner AM, et al. Among authors: clayton pe. Clin Endocrinol (Oxf). 1993 Aug;39(2):201-6. doi: 10.1111/j.1365-2265.1993.tb01774.x. Clin Endocrinol (Oxf). 1993. PMID: 8370133

6

Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.

Patel L, Clayton PE, Brain C, Pelekouda E, Addison GM, Price DA, Mughal MZ. Patel L, et al. Among authors: clayton pe. Clin Endocrinol (Oxf). 1996 Jun;44(6):687-96. doi: 10.1046/j.1365-2265.1996.740561.x. Clin Endocrinol (Oxf). 1996. PMID: 8759181 Clinical Trial.

7

Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency.

Gill MS, Toogood AA, Jones J, Clayton PE, Shalet SM. Gill MS, et al. Among authors: clayton pe. J Clin Endocrinol Metab. 1999 Apr;84(4):1288-95. doi: 10.1210/jcem.84.4.5608. J Clin Endocrinol Metab. 1999. PMID: 10199769

8

Relationship between serum and urinary insulin-like growth factor-I through childhood and adolescence: their use in the assessment of disordered growth.

Hall CM, Gill MS, Foster P, Pennells L, Tillmann V, Jones J, Price DA, Clayton PE. Hall CM, et al. Among authors: clayton pe. Clin Endocrinol (Oxf). 1999 May;50(5):611-8. doi: 10.1046/j.1365-2265.1999.00699.x. Clin Endocrinol (Oxf). 1999. PMID: 10468927

9

Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.

Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE. Aguiar-Oliveira MH, et al. Among authors: clayton pe. J Clin Endocrinol Metab. 1999 Nov;84(11):4118-26. doi: 10.1210/jcem.84.11.6133. J Clin Endocrinol Metab. 1999. PMID: 10566659

10

Serum leptin and body composition in children with familial GH deficiency (GHD) due to a mutation in the growth hormone-releasing hormone (GHRH) receptor.

de A Barretto ES, Gill MS, De Freitas ME, Magalhães MM, Souza AH, Aguiar-Oliveira MH, Clayton PE. de A Barretto ES, et al. Among authors: clayton pe. Clin Endocrinol (Oxf). 1999 Nov;51(5):559-64. doi: 10.1046/j.1365-2265.1999.00837.x. Clin Endocrinol (Oxf). 1999. PMID: 10594516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page